TANK binding kinase 1 (TBK1) could serve as a prognostic biomarker for patients with renal papillary cell carcinoma

• Jie Du,
• Dechao Feng,
• Guo Chen

Affiliations

Jie Du

Department of Urology and Pelvic Surgery, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China

Dechao Feng

Corresponding author.; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China

Guo Chen

Corresponding author. Department of Urology and Pelvic surgery, West China School of Public Health and West China, Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.; Department of Urology and Pelvic Surgery, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China